Joseph Adan
Psychiatry · Clearwater, FLNPI 1609832203
Payments from drug & device makers
Across 228 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$909
- Sunovion Pharmaceuticals Inc.$708
- Neurocrine Biosciences, Inc.$398
- Otsuka America Pharmaceutical, Inc.$277
- Alkermes, Inc.$250
- Vanda Pharmaceuticals Inc.$200
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,21299%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $909 |
| Sunovion Pharmaceuticals Inc. | 37 | $708 |
| Neurocrine Biosciences, Inc. | 26 | $398 |
| Otsuka America Pharmaceutical, Inc. | 18 | $277 |
| Alkermes, Inc. | 14 | $250 |
| Vanda Pharmaceuticals Inc. | 7 | $200 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $167 |
| Johnson & Johnson | 9 | $164 |
| Jazz Pharmaceuticals Inc. | 8 | $148 |
| Bausch Health US, LLC | 7 | $131 |
| Teva Pharmaceuticals USA, Inc. | 7 | $119 |
| Ironshore Pharmaceuticals Inc. | 5 | $108 |
| Lundbeck LLC | 5 | $102 |
| Eisai Inc. | 4 | $83 |
| Shire North American Group Inc | 4 | $71 |
| Tris Pharma Inc | 4 | $64 |
| Neos Therapeutics, LP | 3 | $61 |
| Adlon Therapeutics L.p. | 3 | $55 |
| Alfasigma USA, Inc. | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Corium, LLC | 2 | $42 |
| Noven Therapeutics, LLC | 2 | $25 |
| Brainsway USA Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Merck | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$4,259 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 18 | $26,155 |
| Oxcarbazepine | 33 | $4,046 |
| Clozapine | 29 | $3,940 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 104 | $3,034 |
| Naltrexone Hcl | 42 | $2,248 |
| Paliperidone ErPaliperidone | 13 | $2,147 |
| Quetiapine Fumarate | 109 | $1,840 |
| Clonazepam | 198 | $1,678 |
| Trazodone Hcl | 92 | $1,337 |
| Atomoxetine Hcl | 12 | $1,240 |
| Divalproex Sodium | 25 | $1,229 |
| Risperidone | 112 | $1,130 |
| LoxapineLoxapine Succinate | 12 | $1,070 |
| Aripiprazole | 59 | $1,053 |
| Carbamazepine | 15 | $758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $909 | $26,15518 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $119 | $1,07012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Clearwater
- Michelle ScargleClearwater$926K
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.